BlackRock acquired a "blood bank" and a pharmaceutical laboratory for $ 1.5 billion
The American BlackRock fund has invested in the biotechnology sector, buying a blood bank and a laboratory worth $ 1.5 billion.
The world's largest American investment fund, BlackRock, has acquired a blood bank and a pharmaceutical laboratory for a total of $1.5 billion.
These facilities include a blood processing facility and a high-tech laboratory, reflecting the foundation's desire to expand its presence in the biotechnology sector.
The deal underscores BlackRock's interest in developing medical technology and strengthening its position in the life sciences industry, which is becoming an increasingly attractive destination for large institutional investors.
The editorial board is not responsible for the content and accuracy of material taken, sent or obtained from other sources. The publication of such materials is for informational purposes only and does not imply automatic endorsement or approval of their content.
